A high level of LRRC3B hypermethylation was noted not only in RCC patients (74%), but also in healthy donors (33%) in our study, questioning the use of this gene for the diagnosis of renal cancer on cfDNA. This evidence concerns the gene LRRC3B and renal carcinoma.